GOLDMAN DOWNGRADES COMCAST TO NEUTRAL FROM BUY Goldman Sachs analyst Anthony Noto says his "extreme downside scenario" for Comcast (CMCSA) is playing out worse than he thought. He notes that Comcast cut guidance due to tougher macro conditions, continued competition.

CAMBRIDGE-BASED drugs group CeNeS Pharmaceuticals said it was expecting to reach key milestones in each of its programmes in the next year to 18 months